Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Sep 13 - Sep 18
This guide breaks down everything you need to knowfrom its benefits to side effects, dosage, and legal status
Protocol approach 1: immune rebalancing (thymosin alpha-1 plus KPV) Goal: Restore regulatory immune function while reducing inflammatory signaling Components: Thymosin alpha-1: 1.6 mg subcutaneously twice per week (promotes Treg expansion, modulates dendritic cells) KPV: 200-500 mcg daily, orally or subcutaneously (inhibits NF-kB, reduces TNF-alpha and IL-6) Rationale: Thymosin alpha-1 works at the cellular level to rebuild the regulatory arm of the immune system, while KPV addresses the inflammatory signaling that drives acute symptoms
Single peptide versus stack Individual BPC-157 or TB-500 use provides meaningful benefits for many applications
The authors cited the scientific foundation provided by these studies as supporting ongoing and projected clinical trials in dermal wound repair, corneal injuries, and cardiac and CNS tissue regeneration
However, neither is FDA-approved for human use and both are banned in many athletic contexts
Many are runners, lifters, CrossFitters, or weekend athletes
